Jim Cramer, a famous financial expert, gave his opinions on different energy, health and retail stocks. He liked ONEOK, a big energy company, and suggested people buy more of its shares. He also said people should not buy Dexcom, a company that makes devices to check blood sugar levels. He thinks Dexcom has some problems and its shares are not a good investment. He also talked about other companies like KeyCorp, a bank, and CRISPR Therapeutics, a biotech company. Read from source...

- Cramer's recommendation is based on his personal opinion and past performance of the stocks, not on a rigorous analysis of the current market conditions and the company's fundamentals.
- He does not provide any sources or data to support his claims, making them questionable and unreliable.
- He does not address the potential risks and challenges that the companies he recommends or warns against may face in the future, making his advice incomplete and short-sighted.
- He uses emotional language and personal anecdotes to persuade his audience, rather than logical reasoning and factual evidence.
- He does not acknowledge the diversity of opinions and perspectives that may exist among his viewers and readers, making his advice overly simplistic and one-sided.

### Final answer: This article is a biased and unreliable source of financial advice, as it is based on Cramer's personal opinions and emotional arguments, not on a thorough and objective analysis of the stocks and the market.

I am going to analyze the paragraph above and provide a comprehensive investment recommendation based on the information provided.

Oneok OKE is "terrific" according to Jim Cramer. He recommends buying more of the stock because the company has a strong bank. This is a positive investment recommendation for Oneok.

Dollar Tree DLTR is not recommended by Jim Cramer. He thinks that people have discovered that the small form is no longer working for them and they would rather go to Walmart WMT or Costco COST. This is a negative investment recommendation for Dollar Tree.

Jim Cramer recommends staying away from Dexcom, Inc. DXCM. He says that Dexcom had a real bad miss and they still haven't fully explained why that is. This is a negative investment recommendation for Dexcom.

KeyCorp KEY is a stock that Jim Cramer says "Definitely keep Key. Key is very, very strong, a terrific, terrific bank." This is a positive investment recommendation for KeyCorp.

Jim Cramer said he would be a buyer of CRISPR Therapeutics AG CRSP. This is a positive investment recommendation for CRISPR Therapeutics.

Risks:
There are no explicit risks mentioned in the paragraph above. However, some potential risks may include:
- The stock prices mentioned may fluctuate based on market conditions and other factors.
- The investment recommendations are based on Jim Cramer's opinions, which may not align with the individual investor's goals and risk tolerance.

Final decision:
Based on the information provided, I am going to provide a comprehensive investment recommendation for each stock mentioned.

Oneok OKE: BUY - Jim Cramer's positive recommendation and strong bank indicate that Oneok may be a good investment opportunity.

Dollar Tree DLTR: SELL - Jim Cramer's negative recommendation and the shift in consumer preferences towards Walmart and Costco suggest that Dollar Tree may not be a good investment opportunity.

Dexcom DXCM: SELL - Jim Cramer's negative recommendation and the company's recent miss indicate that Dexcom may not be a good investment opportunity.

KeyCorp KEY: BUY - Jim Cramer's positive recommendation and strong bank indicate that KeyCorp may be a good investment opportunity.

CRISPR Therapeutics AG CRSP: BUY - Jim Cramer's positive recommendation and the company's narrower-than-expected quarterly loss indicate that CRISPR Therapeut